For many adults with ADHD, the question is not just "will this medication work?" but "which kind of medication makes sense for my life?" Strattera and Adderall both treat ADHD effectively — but they work in fundamentally different ways, and the difference matters for how they're prescribed, how quickly they work, and who they fit best.
What Is Adderall?
Adderall is the brand name for mixed amphetamine salts — a combination of dextroamphetamine and levoamphetamine salts in a 3:1 ratio. It is a central nervous system stimulant in the Schedule II controlled substance class, meaning it has recognized medical use but significant potential for dependence and misuse.
Adderall works by increasing the release and blocking the reuptake of dopamine and norepinephrine in the brain — a mechanism that directly addresses the dopaminergic and noradrenergic deficits associated with ADHD. The result is increased attention, reduced impulsivity, and improved executive function.
Adderall comes in two formulations: Adderall IR (immediate-release, lasting 4–6 hours) and Adderall XR (extended-release, lasting 8–12 hours). Generic versions of both are widely available. Adderall is FDA-approved for ADHD in adults and children aged 3 and older, and for narcolepsy.
What Is Strattera?
Strattera is the brand name for atomoxetine, a selective norepinephrine reuptake inhibitor (NRI) — the first non-stimulant medication FDA-approved for ADHD in both children and adults. It is not a controlled substance.
Unlike Adderall, which primarily works through dopamine, atomoxetine works almost entirely through the norepinephrine system. It blocks the norepinephrine transporter in the prefrontal cortex, increasing norepinephrine availability in circuits involved in attention, working memory, and impulse control. Because it does not directly stimulate the dopamine reward pathway the way amphetamines do, it has a much lower abuse potential and no significant street value.
Generic atomoxetine became available in 2017, substantially reducing its cost. Strattera is FDA-approved for ADHD in adults and children aged 6 and older.
Key Differences Between Strattera and Adderall
| | Strattera (atomoxetine) | Adderall (amphetamine salts) |
|---|---|---|
| Mechanism | Norepinephrine reuptake inhibitor (non-stimulant) | Stimulant (dopamine + norepinephrine release + reuptake block) |
| Controlled substance | No (Schedule IV) | Yes (Schedule II) |
| Onset of action | 4–6 weeks for full effect | 30–60 minutes for initial effect |
| Duration | 24 hours (continuous) | IR: 4–6 hours; XR: 8–12 hours |
| Abuse potential | Low — does not produce euphoria | Higher — Schedule II with known abuse potential |
| Effectiveness evidence | Moderate; effect size smaller than stimulants in meta-analyses | Strong; largest evidence base in ADHD pharmacotherapy |
| Anxiety | Does not worsen; may help comorbid anxiety | Can worsen anxiety or agitation in sensitive patients |
| Sleep | Generally does not disrupt sleep; sometimes improves it | Evening doses can cause insomnia |
| Appetite/weight | Modest appetite suppression; less pronounced than stimulants | Significant appetite suppression, especially at first |
| Liver monitoring | Rare hepatotoxicity; patients should report jaundice or abdominal pain | No hepatic concerns |
| Cost | Generic available; varies by plan | Generic available; typically less expensive than Strattera |
How Effective Is Strattera Compared to Adderall?
In meta-analyses of ADHD pharmacotherapy, stimulants — including amphetamines like Adderall — consistently show larger effect sizes than non-stimulants like atomoxetine. The typical finding is that stimulants produce a 60–70% response rate, while atomoxetine produces a 45–50% response rate, with smaller average symptom reduction per treated patient.
That said, response rates are group-level statistics. Some patients do better on atomoxetine than on any stimulant they've tried — either because the stimulant side effect profile was intolerable, because a comorbid anxiety disorder made stimulants a poor fit, or simply because of individual neurobiological variation.
The other advantage that does not show up in symptom-rating scales is coverage: Strattera's 24-hour profile includes the early morning hours and late evening — times when stimulant XR formulations have typically worn off. For people whose ADHD symptoms cause the most difficulty before 9 AM or after 6 PM, this matters.
When Psychiatrists Choose Strattera
Atomoxetine tends to be chosen when:
- Stimulants are contraindicated or have been poorly tolerated. History of stimulant-induced psychosis, severe tics, uncontrolled hypertension, or structural heart disease can make stimulant use unsuitable. Atomoxetine is not risk-free, but it does not carry these contraindications.
- A substance use disorder is present or in the history. Because Strattera is not a controlled substance and does not activate the dopamine reward circuit, it is substantially lower risk in patients with active or past stimulant misuse. This is one of the most common reasons it is chosen over Adderall.
- Anxiety is also present. Stimulants can worsen anxiety — not always, but often enough that in patients with comorbid generalized anxiety disorder or social anxiety, a non-stimulant that does not exacerbate anxiety is worth trying first.
- The patient's work or lifestyle makes Schedule II prescriptions impractical. Some professions, transportation roles, or custody situations make having a Schedule II stimulant prescription genuinely complicated. Atomoxetine avoids those complexities.
- 24-hour symptom coverage is a priority. Adderall XR typically covers 8–12 hours. Strattera covers the full day, including early morning and late evening — useful when ADHD is creating problems before and after the normal workday.
- The patient is 6–18 years old and anxiety is also present. In pediatric patients with ADHD plus anxiety, non-stimulant treatment is often tried first.
When Psychiatrists Choose Adderall
Amphetamine salts tend to be chosen when:
- Evidence-based first-line treatment is the priority. Stimulants have the strongest evidence base in ADHD pharmacotherapy. For an adult with straightforward ADHD and no contraindications, Adderall XR or a similar amphetamine is typically the first-line recommendation.
- Rapid onset is important. Adderall works the same day. A patient who needs to function well at work during a difficult week cannot wait 4–6 weeks to find out if Strattera is working. Stimulants provide immediate feedback.
- Stimulants have worked well in the past. Prior response is one of the strongest predictors of future response. If a patient has done well on an amphetamine before, there is usually no clinical reason to switch to a non-stimulant.
- Cost is a priority. Generic amphetamine salts are typically less expensive than generic atomoxetine, and generic Adderall XR is widely available. Cost comparison will vary by pharmacy and insurance plan.
A Note on Strattera's Black Box Warning
Strattera carries an FDA black box warning for increased risk of suicidal thinking in children and adolescents. This does not mean it causes suicide — clinical trials found no completed suicides and the absolute risk was small — but it does mean that patients under 24 should be monitored closely during the first few months, particularly for new or worsening depression or suicidal thoughts. This warning is similar to those carried by antidepressants in the same age group.
In adults, this warning is less of a clinical concern, though monitoring for mood changes early in treatment is still good practice.
Practical Prescribing Considerations
One practical difference that matters: Adderall requires a Schedule II prescription in most states, which means no refills, a written or electronically controlled prescription each month, and for some patients, pharmacy availability issues during shortage periods. Strattera prescriptions can be refilled and managed like any other non-controlled medication.
Insurance coverage varies significantly for both. Some plans require prior authorization for brand-name Adderall or require generic atomoxetine before covering Vyvanse or Concerta. Checking your pharmacy benefit before the initial prescription saves a common headache.
When to Get Evaluated
If you are an adult who has not been evaluated for ADHD, or who is on a medication that feels like "something is still off," the first step is a thorough evaluation rather than a medication switch on your own.
Our adult ADHD evaluation at SLS Psychiatry reviews the full clinical picture — not just ADHD symptoms, but sleep, mood, anxiety, and other variables that affect how any ADHD medication will perform. Our free ADHD self-screener can help you organize what you are noticing before a visit.